Clinical Trial: A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07560033) titled 'A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects' on April 14.

Brief Summary: This is a randomized, open-label, parallel-controlled study to compare the PK, safety, and immunogenicity of CM326 administered via different delivery devices in healthy subjects.

Study Start Date: April 20

Study Type: INTERVENTIONAL

Condition: Healthy Subjects

Intervention: DRUG: CM326(formulation 1)

subcutaneous injection

DRUG: CM326(formulation 2)

subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Disclaimer: Curated by HT Syndication....